Exicure

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exicure and other ETFs, options, and stocks.

About XCUR

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. 

CEO
Andy Yoo
CEOAndy Yoo
Employees
7
Employees7
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2011
Founded2011
Employees
7
Employees7

XCUR Key Statistics

Market cap
37.22M
Market cap37.22M
Price-Earnings ratio
-3.86
Price-Earnings ratio-3.86
Dividend yield
Dividend yield
Average volume
4.05M
Average volume4.05M
High today
High today
Low today
Low today
Open price
$6.14
Open price$6.14
Volume
0.00
Volume0.00
52 Week high
$22.99
52 Week high$22.99
52 Week low
$3.10
52 Week low$3.10

Stock Snapshot

With a market cap of 37.22M, Exicure(XCUR) trades at $5.76. The stock has a price-to-earnings ratio of -3.86.

On 2025-12-18, Exicure(XCUR) stock opened at $6.14, reached a high of —, and a low of —.

The Exicure(XCUR)'s current trading volume is 0, compared to an average daily volume of 4.05M.

In the last year, Exicure(XCUR) shares hit a 52-week high of $22.99 and a 52-week low of $3.10.

In the last year, Exicure(XCUR) shares hit a 52-week high of $22.99 and a 52-week low of $3.10.

People also own

Based on the portfolios of people who own XCUR. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.